Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Canada’s top edible cannabis producer eyes further growth

The following is a transcription of the above video, and The Market Online has edited it for clarity . Edible cannabis producer, Indiva Ltd. (TSXV:NDVA) , recently announced a LIFE private placement, open to all retail investors, and intends to raise a minimum of $...
Ryan Dhillon | March 20, 2024 |

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'

The new data are reviewed and updates are provided on Can-Fite BioPharma's other clinical studies, including one for COVID-19, in this Dawson James research report. In an April 20 research note, Dawson James analyst Jason Kolbert wrote that results from Can...
Streetwise Reports | April 23, 2020 |

ION Energy: Mongolia's first lithium brine explorer & developer

ION Energy is in the business of exploration and development of lithium brine in Mongolia. ION is currently focused on two projects, their flagship project just 24 km from the Chinese border and another bringing their company to a total of over 110 thousand hectares ...
Daniella Atkinson | January 17, 2023 |

Tracking The Stock Market's Progress Versus Historical Cases

STUDY UPDATE A March 1 analysis covered historical cases similar to the 2019 setup shown below, where the S&P 500’s 100-day moving average (blue) dropped below a flattish-to-down 200-day (red). Stocks rallied and the market closed above the 200-day for el...
Chris Ciovacco | April 9, 2019 |

Peering into the Future of CBD and THC Topical Delivery Products

An innovative product development company with a patented skin delivery technology appears to be making major breakthroughs in the topical and transdermal cannabis space. On April 16, 2019, Ovation Science Inc. ( C.OVAT , Forum ) announced the launch of its new topical...
Dave Jackson | April 24, 2019 |

FDA Grants Breakthrough Status to Biopharma's Lead Candidate for Liver Disease

The California firm's most advanced asset is advancing through Phase 2b, according to a ROTH Capital Partners report. In a Feb. 19 research note, analyst Yasmeen Rahimi reported that CymaBay Therapeutics Inc. (CBAY:NASDAQ) is having a strong Q1/19 with respect to cont...
Streetwise Reports | February 26, 2019 |

Biotech to Launch Preclinical Studies of Antibody in Eight Cancer Types

This company's new trials, preferred dosing and upcoming biologics license application submission are discussed in an H.C. Wainwright & Co. report. In a Feb. 20 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that CytoDyn Inc. (CYDY:OTCQB) plans to...
Streetwise Reports | March 1, 2019 |

Price Target Raised on Biopharma Ahead of Leukemia Trial Update

The expected data and their implications were addressed in a ROTH Capital Partners report. In an April 29 research report, analyst Jotin Marango reported that ROTH Capital Partners raised its price target on ArQule Inc. (ARQL:NASDAQ) to $10 per share in an...
Streetwise Reports | May 9, 2019 |

Top Pick Status Given to Small-Cap with Pain Drug Candidate

The primary reason for the rating—upcoming trial results—is discussed in an Echelon Wealth Partners report. In a July 10 research note, analyst Douglas Loe reported that Echelon Wealth Partners bestowed Top Pick status on Antibe Therapeutics Inc. (ATE:TSX.V...
Streetwise Reports | July 19, 2019 |

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...
Streetwise Reports | August 28, 2019 |
1 2 3 4